NEW YORK (GenomeWeb) – Rubicon Genomics today announced a non-exclusive distribution agreement for its ThruPlex Plasma-seq kits with Beckman Coulter Life Sciences.

Under the terms of the agreement, Beckman Coulter will distribute the kits in the US and Canada. Financial and other details were not disclosed.

The kits prepare next-generation sequencing libraries for whole-genome, whole-exome, and targeted gene sequencing of circulating cell-free DNA in plasma. They are intended for use with Illumina sequencing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

Sponsored by

This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.